LLY

1,095.21

-2.64%↓

JNJ

226.73

-2.05%↓

ABBV

216.57

-1.01%↓

UNH

379.19

-1.44%↓

MRK

118.67

-1.27%↓

LLY

1,095.21

-2.64%↓

JNJ

226.73

-2.05%↓

ABBV

216.57

-1.01%↓

UNH

379.19

-1.44%↓

MRK

118.67

-1.27%↓

LLY

1,095.21

-2.64%↓

JNJ

226.73

-2.05%↓

ABBV

216.57

-1.01%↓

UNH

379.19

-1.44%↓

MRK

118.67

-1.27%↓

LLY

1,095.21

-2.64%↓

JNJ

226.73

-2.05%↓

ABBV

216.57

-1.01%↓

UNH

379.19

-1.44%↓

MRK

118.67

-1.27%↓

LLY

1,095.21

-2.64%↓

JNJ

226.73

-2.05%↓

ABBV

216.57

-1.01%↓

UNH

379.19

-1.44%↓

MRK

118.67

-1.27%↓

Home・Akciju saraksts・Pulmatrix Inc

Pulmatrix Inc

Atvērts

1.32 -5.04

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.24

Max

1.38

Galvenie mērījumi
By Trading Economics
Ienākumi	-244K -1.2M
EPS	-0.321
Darbinieki	2
EBITDA	-364K -1.3M

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	256K 4.8M
Iepriekšējā atvēršanas cena	6.36
Iepriekšējā slēgšanas cena	1.32

Pulmatrix Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 28. maijs 22:47 UTC

Peļņas

Costco 3Q Sales Rise as Value Offerings Draw Pressured Consumers -- Update

2026. g. 28. maijs 20:45 UTC

Peļņas

Costco 3Q Profit Rises as Value Offerings Draw Pressured Consumers

2026. g. 28. maijs 23:43 UTC

Tirgus saruna

Nikkei May Rise on Hopes for U.S.-Iran Peace Deal -- Market Talk

2026. g. 28. maijs 23:39 UTC

Tirgus saruna

Gold Edges Lower as Traders Assess Potential U.S.-Iran Deal -- Market Talk

2026. g. 28. maijs 23:31 UTC

Tirgus saruna

KMD Could Realize Value From Selling Either Oboz or Rip Curl -- Market Talk

2026. g. 28. maijs 23:17 UTC

Tirgus saruna

Mainfreight Steering Its Way Out of Tough Period -- Market Talk

2026. g. 28. maijs 23:02 UTC

Tirgus saruna

Costco Has Started Submitting Tariff Refund Claims -- Market Talk

2026. g. 28. maijs 22:41 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 28. maijs 22:41 UTC

Tirgus saruna

MongoDB Still Getting More Growth From Established Customers Than AI -- Market Talk

2026. g. 28. maijs 22:37 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

M&A-Related Insurance Payments In North America Rise -- Market Talk

2026. g. 28. maijs 22:04 UTC

Iegādes, apvienošanās, pārņemšana

CN: Surface Transportation Board Was Right to Freeze the UP-NS Merger and Demand More Info

2026. g. 28. maijs 22:04 UTC

Iegādes, apvienošanās, pārņemšana

CN: This Confirms What CN and Many Stakeholders Have Said All Along, UP and NS Still Have Not Submitted a Credible Case to Support Their Proposed Merger >CNI

2026. g. 28. maijs 21:12 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

2026. g. 28. maijs 21:00 UTC

Peļņas

Dell Stock Soars on Blowout Earnings. The Outlook Bests Analysts by $20 Billion. -- Barrons.com

2026. g. 28. maijs 20:57 UTC

Peļņas

Dell Stock Soars on Blowout Earnings -- Barrons.com

2026. g. 28. maijs 20:55 UTC

Peļņas

Costco Wholesale Sees a Mixed Quarter, Misses Earnings Estimates -- Barrons.com

2026. g. 28. maijs 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 28. maijs 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 28. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 28. maijs 20:48 UTC

Karstas akcijas

Stocks to Watch Recap: Snowflake, Union Pacific, Hormel Foods -- WSJ

2026. g. 28. maijs 20:34 UTC

Peļņas

One of the S&P 500's Highest Dividends Looks Even Better Now -- Barrons.com

2026. g. 28. maijs 20:31 UTC

Peļņas

Li and XPeng Both Miss Earnings Estimates. One Chinese EV Maker's Stock Is Rising. -- Barrons.com

2026. g. 28. maijs 20:28 UTC

Peļņas

Best Buy's 5% Dividend Yield Looks Even Better After Earnings -- Barrons.com

2026. g. 28. maijs 20:26 UTC

Peļņas

Dell Stock Soars on Blowout Earnings -- Barrons.com

2026. g. 28. maijs 20:20 UTC

Peļņas

Costco 3Q Membership Fees $1.37B

2026. g. 28. maijs 20:20 UTC

Peļņas

Costco 3Q Net Sales $69.15B

2026. g. 28. maijs 20:19 UTC

Peļņas

Costco 3Q Adj Same-Store Sales, Which Excludes Impacts From Gas Prices and Foreign Exchange, Rose 6.6% >COST

2026. g. 28. maijs 20:19 UTC

Peļņas

Costco 3Q Adjusted Digitally-Enabled Sales Rose 20.8% >COST

2026. g. 28. maijs 20:17 UTC

Peļņas

Costco 3Q Digitally-Enabled Sales Rose 21.5% >COST

2026. g. 28. maijs 20:17 UTC

Peļņas

Costco 3Q Same-Store Sales Up 9.8% >COST

Salīdzinājums

Cenas izmaiņa

Pulmatrix Inc Prognoze

Vērtējuma vienprātība

By TipRanks

0 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 0 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Pulmatrix Inc — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.